Health
Monoclonal antibodies can help high-risk people with COVID-19. But getting the drug to patients remains challe – The Philadelphia Inquirer
Demand for the drugs, which are the only approved treatment for high-risk patients who don’t need to be in the hospital, is lower than expected.
Back in December, the big worry about two newly approved treatments for early COVID-19 was that demand would far outstrip supply.
After all, some famous men had taken monoclonal antibodies after they were infected in the fall some of them before the drugs received emergency-use authorization and became highly visible converts.
Former President Donald Trump called a drug made by Regeneron a cure. (He was also given other treatments that may have helped him recover.) Ben Carson, former secretary of…
-
General23 hours agoCanberra man accused of flashing and assaulting 12-year-old girl released on bail
-
Noosa News23 hours agoMan charged with attempted murder after shooting south of Brisbane
-
Noosa News22 hours agoAustralia’s newest rice mill funded largely by farmers
-
Noosa News15 hours agoDaly Cherry-Evans set to be dropped as Maroons captain